Listed company on the Beijing Stock Exchange. The main business of the company is the R&D, production and sales of raw materials and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent. The main products of the company are characterized by relatively complex structure, great difficulty in research and development, high technical barriers, unique production process and high added value. The company's core management team has more than 20 years of industry experience and accumulated rich R&D technology and industrial chain resources. The company has established a long-term and stable cooperative relationship with downstream customers. The main product end market is oriented to overseas standardized markets such as Japan, South Korea, Europe and the United States. The end customers include many multinational companies and other well-known pharmaceutical enterprises.